Autopsy report · NCT03327064
A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer
Cause of deathStaffing, sites or logistics, also slow enrollment
“COVID-19 pandemic, unable to enroll participants”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1, Phase 2
- Sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Conditions
- Non-melanoma Skin Cancer
- Interventions
- UAB30; Placebo
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate
“Covid 19 Pandemic - Unable to enroll patients” - Foley Catheter Induction
“unable to recruit participants due to COVID pandemic” - The Effective Parenting Program (EPP)
“Covid-19 - unable to recruit any participants” - Effects of High Caffeine Content Coffee on Blood Pressure in Young Adults
“not possible to enroll during COVID pandemic” - Paresthesia Free Spinal Cord Stimulation (PF-SCS)
“Unable to recruit subjects due to Covid pandemic”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.